JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market Outperform

September 19, 2016 3:04 PM EDT
Get Alerts SRPT Hot Sheet
Price: $47.98 -2.18%

Rating Summary:
    16 Buy, 8 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade SRPT Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

JMP Securities upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Market Underperform to Market Outperform with a price target of $60.00 (from $10.00).

For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.

Shares of Sarepta Therapeutic closed at $28.15 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades

Related Entities

JMP Securities

Add Your Comment